Follow
Karen Ho
Karen Ho
Clene Nanomedicine, Inc
Verified email at clene.com - Homepage
Title
Cited by
Cited by
Year
Costal2, a novel kinesin-related protein in the Hedgehog signaling pathway
JC Sisson, KS Ho, K Suyama, MP Scott
Cell 90 (2), 235-245, 1997
4291997
Sonic hedgehog in the nervous system: functions, modifications and mechanisms
KS Ho, MP Scott
Current opinion in neurobiology 12 (1), 57-63, 2002
2022002
Drosophila melanogaster: an insect model for fundamental studies of sleep
KS Ho, A Sehgal
Methods in enzymology 393, 772-793, 2005
1042005
OTUD7A regulates neurodevelopmental phenotypes in the 15q13. 3 microdeletion syndrome
M Uddin, BK Unda, V Kwan, NT Holzapfel, SH White, L Chalil, ...
The American Journal of Human Genetics 102 (2), 278-295, 2018
902018
Identification of rare recurrent copy number variants in high-risk autism families and their prevalence in a large ASD population
N Matsunami, D Hadley, CH Hensel, GB Christensen, C Kim, E Frackelton, ...
PloS one 8 (1), e52239, 2013
872013
Chromosomal microarray analysis of consecutive individuals with autism spectrum disorders using an ultra-high resolution chromosomal microarray optimized for neurodevelopmental …
KS Ho, ER Wassman, AL Baxter, CH Hensel, MM Martin, A Prasad, ...
International journal of molecular sciences 17 (12), 2070, 2016
732016
Hedgehog signal transduction proteins: contacts of the Fused kinase and Ci transcription factor with the kinesin-related protein Costal2
V Monnier, KS Ho, M Sanial, MP Scott, A Plessis
BMC developmental biology 2, 1-9, 2002
732002
Nanocatalytic activity of clean-surfaced, faceted nanocrystalline gold enhances remyelination in animal models of multiple sclerosis
AP Robinson, JZ Zhang, HE Titus, M Karl, M Merzliakov, AR Dorfman, ...
Scientific reports 10 (1), 1936, 2020
672020
Differential regulation of Hedgehog target gene transcription by Costal2 and Suppressor of Fused
KS Ho, K Suyama, M Fish, MP Scott
Oxford University Press for The Company of Biologists Limited 132 (6), 1401-1412, 2005
562005
Chromosomal microarray testing identifies a 4p terminal region associated with seizures in Wolf–Hirschhorn syndrome
KS Ho, ST South, A Lortz, CH Hensel, MR Sdano, RJ Vanzo, MM Martin, ...
Journal of Medical Genetics 53 (4), 256-263, 2016
532016
Identification of rare DNA sequence variants in high-risk autism families and their prevalence in a large case/control population
N Matsunami, CH Hensel, L Baird, J Stevens, B Otterud, T Leppert, ...
Molecular Autism 5, 1-18, 2014
422014
Study protocol of RESCUE-ALS: A Phase 2, randomised, double-blind, placebo-controlled study in early symptomatic amyotrophic lateral sclerosis patients to assess bioenergetic …
S Vucic, MC Kiernan, P Menon, W Huynh, A Rynders, KS Ho, ...
BMJ open 11 (1), e041479, 2021
382021
Clinical performance of an ultrahigh resolution chromosomal microarray optimized for neurodevelopmental disorders
KS Ho, H Twede, R Vanzo, E Harward, CH Hensel, MM Martin, S Page, ...
BioMed research international 2016, 2016
252016
Clinical significance of copy number variants involving KANK1 in patients with neurodevelopmental disorders
RJ Vanzo, H Twede, KS Ho, A Prasad, MM Martin, ST South, ...
European journal of medical genetics 62 (1), 15-20, 2019
222019
International meeting on Wolf‐Hirschhorn syndrome: Update on the nosology and new insights on the pathogenic mechanisms for seizures and growth delay
J Nevado, KS Ho, M Zollino, R Blanco, C Cobaleda, C Golzio, ...
American Journal of Medical Genetics Part A 182 (1), 257-267, 2020
192020
A survey of antiepileptic drug responses identifies drugs with potential efficacy for seizure control in Wolf–Hirschhorn syndrome
KS Ho, LM Markham, H Twede, A Lortz, LM Olson, X Sheng, C Weng, ...
Epilepsy & Behavior 81, 55-61, 2018
182018
Analytical and clinical validity study of FirstStepDx PLUS: a chromosomal microarray optimized for patients with neurodevelopmental conditions
C Hensel, R Vanzo, M Martin, S Dixon, C Lambert, B Levy, L Nelson, ...
PLoS currents 9, 2017
132017
Efficacy and safety of CNM-Au8 in amyotrophic lateral sclerosis (RESCUE-ALS study): a phase 2, randomised, double-blind, placebo-controlled trial and open label extension
S Vucic, P Menon, W Huynh, C Mahoney, KS Ho, A Hartford, A Rynders, ...
EClinicalMedicine 60, 2023
92023
Critical exon indexing improves clinical interpretation of copy number variants in neurodevelopmental disorders
ER Wassman, KS Ho, D Bertrand, KW Davis, MM Martin, S Page, A Peiffer, ...
Neurology: Genetics 5 (6), e378, 2019
52019
A case for cannabidiol in Wolf–Hirschhorn syndrome seizure management
KS Ho, ER Wassman
American Journal of Medical Genetics Part A 173 (2), 324-326, 2017
52017
The system can't perform the operation now. Try again later.
Articles 1–20